Outsourcing Intelligence for CRO Teams
Start each day with curated headlines on clinical outsourcing, vendor moves, and regulatory shifts — then read weekly deep dives that connect the news to program risk, capacity, and partner selection.
Feed: /api/seo/feed · Markdown mirrors: /posts/<slug>.md
- Daily newsCRO Daily News — July 24, 2026
- PrimeVigilance Earns Veeva Services Partner Certification for Pharmacovigilance Case Processing
- Daily newsCRO Daily News — July 22, 2026
- SK pharmteco Advances AAV Gene Therapy to Phase III with 20 Clinical Batches for Genethon DMD Program
- Deep diveClinical Trial Recruitment Bottlenecks Drive Outsourcing Demand for CROs
Enrollment failures delay 80% of trials at crushing costs, forcing sponsors to treat patient recruitment as a strategic outsourcing priority rather than a site-level problem—making specialized CROs essential partners in de-risking timelines and protecting market exclusivity.
- Daily newsCRO Daily News — July 17, 2026
- Crown Bioscience Joins C-Path NAMs Coalition to Validate Human-Relevant Preclinical Models
- Daily newsCRO Daily News — July 15, 2026
- CovarsaDx Exhibits IVD Clinical Research Capabilities at ADLM 2026
- Deep diveAI adoption drives 65% of outsourced pharma R&D spending in 2026
AI-driven clinical trial optimization is reshaping pharma outsourcing economics, with CROs that embed AI for patient matching and predictive safety monitoring capturing disproportionate contract value as regulatory clarity enables enterprise-scale deployment. Procurement leaders must now evaluate vendors on AI integration depth and regula
- Daily newsCRO Daily News — June 28, 2026
- Advanced Clinical Partners with Cognitive Clinical Trials to Enhance Alzheimer's Patient Recruitment
- Daily newsCRO Daily News — June 22, 2026
- FDA Streamlines Early-Stage IND Submissions and Late-Stage Trial Evidence Standards
- Daily newsCRO Daily News — June 11, 2026
- HkeyBio Launches NHP Fast-PoC Program for Low-Cost Cynomolgus PK/PD Validation
- Daily newsCRO Daily News — June 6, 2026
- SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver
- Innovent declares Phase 3 success for ADC that attracted huge Takeda deal
- Zifo Transforms EHS Policy Management with New AI-Enabled Services Accelerator
- VetrixBio Announces Positive Clinical Data for VTX-304, a First-in-Class Bispecific Antibody for Canine Osteoarthritis
- Grifols Supports AlphaDetect to Accelerate Detection of Alpha-1